All News

Plenty of experience fixing complications of pelvic reconstruction and incontinence surgery caused by foreign bodies-mainly grafts and slings-led a group of researchers to make recommendations on how to repair the damage.

A trial currently under way may help urologists to separate responders from nonresponders early and tailor BCG therapy for optimal results in those bladder cancer patients who respond to the drug.

It may be time to put surgical-style checklists to use in the office. This article, which details one of the author's own experience, explains why.

San Francisco's diverse and unique offerings-neighborhoods, attractions, arts, culture, and nightlife-are unparalleled in the United States.

As part of reform, It is clear that the government is starting to tighten control of physician-owned ancillary services.

Urologists and their patients may soon be able to determine renal cell tumor histology without surgery or biopsy.

Injections of autologous muscle-derived cells appear to be both safe and effective in the treatment of stress urinary incontinence, with a trend toward greater effectiveness at higher doses.

Overall, most of the urologists who were interviewed considered the CT scan the gold standard for approaching many diagnoses.

What is it going to take for Congress to stop playing games with physicians who treat Medicare patients and develop an effective solution to the fee cuts that are scheduled every year and require last-minute, short-term solutions?

Although the request to revise the urodynamics codes was initiated by Medicare, the request was to change the CPT code descriptions to reflect the fact that the old 51772 and the old 51795 were billed in conjunction with code 51726 almost all the time.

Radical prostatectomy has changed dramatically over the past 20 years. A procedure that once carried a significant degree of perioperative morbidity, particularly in high-risk patients, has become relatively routine in high-volume centers.

Selenium and vitamin are E not promising, but both the Prostate Cancer Prevention Trial and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial showed a 20% to 25% reduction in the incidence of prostate cancer from two different 5-alpha-reductase inhibitors, finasteride (Proscar) and dutasteride (Avodart).

The development of targeted molecular therapies offers new avenues for combining pharmacologic and surgical therapies in the treatment of advanced renal cell carcinoma.

Receiving a diagnosis of prostate cancer is accompanied by significantly increased risks of suicide and cardiovascular death, according to recent results of a U.S. population-based cohort study.

The first-ever presentation of phase III data from the investigational taxane cabazitaxel showed a 30% improvement in survival in men with metastatic castration-resistant prostate cancer.

Researchers for the Urinary Incontinence Treatment Network found that the minimum important difference for the Urogenital Distress Inventory was –35 to –45 points in patients with urge urinary incontinence.

Enough evidence has linked ADT to cardiovascular events and diabetes to warrant a recent science advisory compiled by AUA, the American Heart Association, American Cancer Society, and American Society for Radiation Oncology.

Evidence that percutaneous tibial nerve stimulation is an effective, drug-free treatment for overactive bladder is mounting. A double-blind, sham-controlled, multicenter trial showed a response rate of about 50% in patients who have struggled with symptoms for a decade.

The following pages feature products and services from manufacturers that are exhibiting at the American Urological Association annual meeting in San Francisco. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.

Surgeons who automatically consider radical nephrectomy for small renal tumors are doing their patients a disservice. Data from Memorial Sloan-Kettering Cancer Center and other centers suggest that partial nephrectomy is more appropriate, especially for smaller tumors.

A major cause of concern among urologists and other physicians with large Medicare patient practices is a provision in the new law that will establish a new Independent Payment Advisory Board that is charged with reducing the per capita rate of growth in Medicare spending indefinitely.

Studies are revealing a genetic basis for stress urinary incontinence and pelvic organ prolapse and are showing that the two conditions are more disparate than previously thought.

The American Association of Clinical Urologists has always been the political voice for organized urology and believes that urologists themselves must speak to elected officials directly.

Caris Life Sciences (Irving, TX) has announced the launch of its urologic pathology practice, available through its subsidiary Caris Diagnostics.

Blue Shield of California now covers the Renessa System (Novasys Medical, Inc., Newark, CA) treatment for non-pregnant women diagnosed with moderate to severe stress urinary incontinence who are unable or unwilling to undergo surgery.

Cancer often leads to significant and long-term disruption in sexual function and intimacy, regardless of the type of cancer or how far along the patient is in the treatment plan, say researchers from Duke Clinical Research Institute, Durham, NC.

Men with prostate cancer are at increased risk of thromboembolism, particularly those receiving hormone therapy, according to a recent study.